projects

 

 

Ongoing:

PRELUDIUM no. 2022/45/N/NZ7/04059, 2023-2025

PI: Magadalena Białoń

The evaluation of therapeutic potential of β-caryophyllene in animal schizophrenia model – behavioral and molecular studies

Source of funding: National Science Centre, Kraków, Poland, the amount allocated: 138 803 PLN

OPUS no. 2021/43/B/NZ7/01162, 2023-2027

PI: Katarzyna Starowicz-Bubak

Cognitive dysfunction in chronic pain – the underestimated importance of CBD

Source of funding: National Science Centre, Kraków, Poland, the amount allocated: 2 889 326 PLN

PRELUDIUM no. UMO-2021/41/N/NZ7/01248, 2022-2024

PI: Marta Kędziora

Novel hope for diseased joints: a polymer-based treatment to promote regenerative strategies for patients with osteoarthritis

Source of funding: National Science Centre, Kraków, Poland, the amount allocated: 139 995 PLN

OPUS no. UMO-2019/35/B/NZ7/01176, 2020-2024

PI: Katarzyna Starowicz-Bubak

Endocannabinoid regulation of the motivational tone at the mesolimbic system driven by inflammation

Source of funding: National Science Centre, Kraków, Poland, the amount allocated: 2 852 070 PLN

SONATA

Completed:

OPUS no. UMO-2016/23/B/nZ7/01143, 2017-2020

PI: Katarzyna Starowicz-Bubak

The role of synovial fibroblasts’ activity in joint pain in osteoarthritis

Source of funding: National Science Centre, Kraków, Poland, the amount allocated: 1 649 791 PLN

OPUS no. 2014/13/B/NZ7/02311, 2015-2018

PI: Katarzyna Starowicz-Bubak

Targeting peripheral cannabinoid receptors CB2 as a novel therapy to treat osteoarthritis

Source of funding: National Science Centre, Kraków, Poland, the amount allocated: 1 553 250 PLN

SONATA BIS no. 2012/07/E/NZ7/01269, 2013-2017

PI: Katarzyna Starowicz-Bubak

Investigation for pharmacotherapy of osteoarthritis (OA): TRPV1 and CB1 receptors and their endogenous ligands as new targets for pharmacological intervention

Source of funding: National Science Centre, Kraków, Poland, the amount allocated: 1 497 000 PLN

ETIUDA no. 2015/16/T/NZ7/00052, 2015-2016

PI: Natalia Małek

Znaczenie interakcji układu endokanabinoidowego i endowaniloidowego w leczeniu bólu przewlekłego – potencjał terapeutyczny związków hybrydowych

Source of funding: National Science Centre, Kraków, Poland, the amount allocated: 106 576 PLN

DIAMENTOWY GRANT no. 0044/DIA/2013/42, 2013-2015

PI: Natalia Małek

Endocannabinoids as potential drugs that inhibit the development of osteoarthritis and affect the regeneration of articular cartilage – in vitro tests and in vivo

Source of funding: Ministry of Science and Higher Education, Warsaw, Poland amount allocated: 190 300 PLN

LIDER/29/60/L-2/10/NCBiR/2011, 2011-2014

PI: Katarzyna Starowicz-Bubak

The interaction between endocannabinoids and endovanilloids as a new therapeutic target in neuropathic pain

Source of funding: National Centre for Research and Development (NCBiR) amount allocated: 989 000 PLN

MNiSW N N401 015235, 2008-2011

PI: Katarzyna Starowicz-Bubak

Defining the role of spinal vanilloid receptors and their endogenous ligands in pharmacology and treatment of neuropathic pain

Source of funding: Ministry of Science and Higher Education, Warsaw, Poland amount allocated: 400 000 PLN

HOMING FNP, 2007-2011

PI: Katarzyna Starowicz-Bubak

The role of spinal TRPV1 vanilloid receptors in the analgesic effects of anandamide in a model of neuropathic pain

Source of funding: Foundation for Polish Science amount allocated: 120 000 PLN